STOCK TITAN

Avadel Pharmaceuticals to Participate in Fireside Chats at Upcoming March 2021 Investor Conferences

Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced participation in fireside chats at the H.C.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced participation in fireside chats at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021 and the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021. The management team will discuss the company's investigational drug, FT218, a once-nightly formulation of sodium oxybate for treating narcolepsy-related symptoms. Webcasts of these events will be available on the company's website for 90 days following the presentations.

Loading...
Loading translation...
Argus Session date unavailable
-2.20% session move Open Argus
Details

News Market Reaction – AVDL

The recorded move for AVDL in the trading session of this news was -2.20%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DUBLIN, Ireland, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that members of the Avadel management team will participate in fireside chats at the H.C. Wainwright Global Life Sciences Conference and Oppenheimer 31st Annual Healthcare Conference which are being held in March 2021.

Fireside Chat Details:
Event:H.C. Wainwright Global Life Sciences Conference
Date:March 9th
Webcast:A webcast of this event will be available starting at 7 a.m. ET on Tuesday, March 9th, at (click here), as well as on Avadel’s website, www.avadel.com, with an archive available for 90 days.
  
Event:Oppenheimer 31st Annual Healthcare Conference
Time and Date:3:10 p.m. ET on Wednesday, March 17th  
Webcast:A live webcast of this event, as well as an archived recording, will be available at (click here), as well as on Avadel’s website, www.avadel.com, for 90 days from being made available.

Contacts:

 Tom McHugh
 Chief Financial Officer
 Phone: (636) 449-1843
 Email: tmchugh@avadel.com
  
 Tim McCarthy
 LifeSci Advisors, LLC
 Phone: (212) 915-2564
 Email: tim@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the purpose of Avadel Pharmaceuticals participating in the March 2021 conferences?

Avadel Pharmaceuticals is participating in the conferences to discuss their investigational drug FT218 for narcolepsy.

When will Avadel present at the H.C. Wainwright Global Life Sciences Conference?

Avadel will present at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021.

What time is Avadel's presentation at the Oppenheimer 31st Annual Healthcare Conference?

Avadel's presentation at the Oppenheimer 31st Annual Healthcare Conference is scheduled for 3:10 p.m. ET on March 17, 2021.

Where can I find the webcasts of Avadel's conference presentations?

The webcasts will be available on Avadel's website and will remain accessible for 90 days after the events.

What is FT218 that Avadel Pharmaceuticals is discussing at these conferences?

FT218 is an investigational once-nightly formulation of sodium oxybate aimed at treating excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Keep reading